NASDAQ closes at all-time high, but COVID a concern

Published 21-JUL-2020 08:59 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

While global markets were generally buoyant overnight, the ASX is likely to be influenced by growing coronavirus rates and today’s announcement regarding changes to JobSeeker and JobKeeper by the Australian government.

The ASX SPI200 futures index suggests we are in for a positive day, offsetting yesterday’s fall of 0.5% in the S&P/ASX 200 index.

Energy stocks placed a drag on the market yesterday with the index falling from 6033 points to less than 6000 points midway through the session before recovering to close at 6002 points.

Ahead of the open, the futures index is up 42 points to 6012 points.

24 hours

The Shanghai Composite was the star performer in the Asia-Pacific region yesterday, gaining 100 points or 3.1% to close at 3314 points.

The index has traded erratically in July, surging from about 3000 points to 3450 points early in the month before retracing to approximately 3200 points last week.

Whether yesterday’s rally represents the start of another leg up remains to be seen.

Other indices were relatively flat with the Hang Seng shedding 0.1% to close at 25,058 points and the Nikkei 225 gaining 0.1% as it closed at 22,717 points.

European markets were mixed with the FTSE 100 coming off 29 points or 0.5% to close at 6261 points.

There was much more confidence in mainland Europe with the DAX gaining 1% to 13,046 points.

The CAC 40’s close of 5093 points represented a gain of 0.5%.

The most significant development in the US was the NASDAQ’s 2.5% surge as it gained 264 points to close at 10,767 points, its highest close on record.

Amazon was the big mover, soaring nearly 8% after brokers increased their share price targets to US$3800 per share.

Interestingly, the Dow Jones US Retail Index gained 3.5% to close at a record high, difficult to fathom given increasing unemployment, lower levels of disposable income among consumers and a significant erosion in consumer confidence, economic stability and social equilibrium in the face of ongoing riots.

The Dow was relatively flat, only gaining nine points to close at 26,680 points.

The S&P 500 was perhaps a better measure of broader investor sentiment as it rallied 0.8% to 3251 points.

After dipping early in the day, the Brent Crude Oil Continuous Contract recovered to close at US$43.28 per barrel.

Gold hit an intraday high of US$1823 per ounce, just shy of the long-term high recorded earlier this month.

Iron ore came off 0.7%, closing at US$109.50 per tonne.

There was little movement in base metal prices.

The Australian dollar continued to strengthen against the US dollar, and it is now fetching just above US$0.70, having gained more than 2% in the last three weeks.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X